Yes, a low white blood cell (WBC) count can be a concern for individuals undergoing treatment for myeloma, as it increases the risk of infections. This can happen due to the impact of chemotherapy, radiation therapy, or stem cell transplantation, all of which can significantly lower WBC counts.

When a low WBC count is ... read more

Yes, a low white blood cell (WBC) count can be a concern for individuals undergoing treatment for myeloma, as it increases the risk of infections. This can happen due to the impact of chemotherapy, radiation therapy, or stem cell transplantation, all of which can significantly lower WBC counts.

When a low WBC count is detected, doctors may take several steps to manage the situation:
- **Adjusting Treatment**: They might modify your chemotherapy regimen or pause it to allow your WBC count to recover.
- **Medications**: Prescribing medications like filgrastim (Neupogen) or pegfilgrastim (Neulasta) to stimulate the production of white blood cells.
- **Monitoring**: Increasing the frequency of blood tests to closely monitor your WBC count.
- **Infection Prevention**: Advising on preventive measures to reduce the risk of infections, which may include avoiding crowded places, practicing good hygiene, and possibly taking prophylactic antibiotics.

It's crucial to communicate any symptoms or concerns to your healthcare provider, as they can offer personalized advice and adjustments to your treatment plan.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Infections and Myeloma: How To Lower Your Risk | MyMyelomaTeam

Stem Cell Transplants for Multiple Myeloma: Your Guide | MyMyelomaTeam